Zimmer Partners, LP Bridge Bio Pharma, Inc. Transaction History

Zimmer Partners, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $224,270 - $331,690	8,200 Added 12.62%	73,200 $2.26 Million
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $1.56 Million - $2.85 Million	65,000 New	65,000 $2.62 Million
Q1 2020 May 15, 2020	SELL	$16.11 - $36.23 $273,870 - $615,910	-17,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$26.97 - $27.55 $458,490 - $468,350	17,000 New	17,000 $458,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Zimmer Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Zimmer Partners, LP with notifications on news.